Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met
about
Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.Downregulation of miR-139-5p contributes to the antiapoptotic effect of liraglutide on the diabetic rat pancreas and INS-1 cells by targeting IRS1.Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.miR-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1.MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway.MicroRNA-1275 suppresses cell growth, and retards G1/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5.Long Intergenic Noncoding RNA 00511 Acts as an Oncogene in Non-small-cell Lung Cancer by Binding to EZH2 and Suppressing p57.The Novel miR-9600 Suppresses Tumor Progression and Promotes Paclitaxel Sensitivity in Non-small-cell Lung Cancer Through Altering STAT3 Expression.Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC)Long non-coding RNA EWSAT1 promotes human nasopharyngeal carcinoma cell growth in vitro by targeting miR-326/-330-5p.Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway.MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer.MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3ζ/STAT3/HIF-1α/VEGF signalingmiR-134: A Human Cancer Suppressor?Novel miRNA-mRNA interactions conserved in essential cancer pathways.UCA1 involved in the metformin-regulated bladder cancer cell proliferation and glycolysis.Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p/PDK1/AKT axis in hepatocellular carcinoma.Decreased expression of Met during differentiation in rat lung.Hyperthermia-driven aberrations of secreted microRNAs in breast cancer in vitro.Long non-coding RNA-CRNDE: a novel regulator of tumor growth and angiogenesis in hepatoblastomaMicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value.Long non-coding RNA LOC100129148 functions as an oncogene in human nasopharyngeal carcinoma by targeting miR-539-5p.Differential Expression of MicroRNAs in Leprosy Skin Lesions.Long intergenic non-protein coding RNA 00858 functions as a competing endogenous RNA for miR-422a to facilitate the cell growth in non-small cell lung cancer.The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2.Long non-coding RNA XIST promotes cell growth and metastasis through regulating miR-139-5p mediated Wnt/β-catenin signaling pathway in bladder cancer.MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.In vivo magnetofection: a novel approach for targeted topical delivery of nucleic acids for rectoanal motility disorders.miR-455-5p promotes cell growth and invasion by targeting SOCO3 in non-small cell lung cancer.Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer.Candidate miRNAs in human breast cancer biomarkers: a systematic review.Tumor-suppressor role of miR-139-5p in endometrial cancer.Human salivary microRNAs in Cancer.Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma.Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells
P2860
Q33648562-B2FF7AF1-0314-4C06-8886-245FBAD12C4CQ36323971-DD5C22D6-810B-4944-B8B2-B2AD37EFEF9BQ36946799-683A922C-A5D7-43A7-8FE4-CE523E0B4245Q36950630-E61037E5-7686-4DD1-980E-4D8C1C3367A6Q37225326-87A60822-721B-44EC-A868-CAD21E4A163EQ37252292-1C5D72F3-B4EE-40D8-881B-F5E5D141320FQ37392616-3550F4F4-5CE4-4DE7-86BD-27FDDB7E307CQ37423551-3BA005EC-601F-47D6-B5F3-82A20117247FQ37482545-71BC6AAA-63FD-46D4-B2C2-07B8F7D0F070Q37501589-D5548782-C369-414C-BBDF-A06EF41A17E2Q37501595-1BF96FB7-4098-4FF4-A738-809A548E626FQ37520511-774CCE29-DCD0-4E62-A056-129C591E7920Q37530948-7A349607-87CA-4446-8A50-7CAC0D983364Q37588369-62B131C5-4EBC-4F3D-BED2-3D63D584979DQ37682257-E8FD2D9C-3705-4A71-9478-4AF0FF947452Q37694851-A76A038B-BFFF-4903-A4BE-A005D9122C1EQ37718061-519E8D74-33A4-49AC-9C6C-B55B8F534539Q37741366-DBEB446A-C466-4F2C-8157-0D5B483AFFF5Q38699316-56B99231-662C-4DF8-AB79-A8E111C4022EQ38715197-61A398DD-6B66-4B75-B6BB-9FFB2FD20B26Q39233855-1E37BA74-8059-4DD4-92D5-E4EB2D889761Q39630301-23498E8F-49E8-479D-BAE3-79E9E34C3233Q41091888-34F633C6-F059-42F5-B45C-3B6F3E62C3F8Q41347645-9E56B12B-4C1B-4D15-A67F-BE7865750036Q41910784-C122C484-D282-4AC3-8977-5E306C23D346Q41991878-8CAF9435-0EB7-4C64-9725-C8F36B1A1ED0Q42314770-F22C0FC4-CE7B-46CE-991D-A7401C2E65C5Q46675216-7FC9991A-B243-49BC-BE0E-13A5071EDCA4Q47108621-EE4C7949-EA8A-4B6A-A969-08D367A135C0Q47138374-4DC5099B-2A45-4841-A083-769E60B07E32Q47757326-9D8DEAAF-AB1E-43B1-B7F7-B29C00A2E9D2Q49164115-9C225A0F-A79C-4803-B7F6-02EF089C5709Q50125777-F1189442-ECCA-4D48-80E9-B0F0EBE27389Q50171133-23F7C79B-0C06-4577-8F9A-71CC5D1E2FEBQ52606230-F2304635-BC6C-4B78-A3F9-508D122AC97FQ52647687-BF44D95B-697A-4225-9198-5CCF081C7A0BQ55153270-21B7A764-7999-4E19-8CAA-36EDA56A2EDAQ58757340-26E634B5-7F19-4938-A4FF-6C8CA0720F3DQ58800444-8B4A3F7C-A9C9-46A4-B422-182AD0095D91
P2860
Hsa-miR-139-5p inhibits proliferation and causes apoptosis associated with down-regulation of c-Met
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hsa-miR-139-5p inhibits prolif ...... with down-regulation of c-Met
@ast
Hsa-miR-139-5p inhibits prolif ...... with down-regulation of c-Met
@en
type
label
Hsa-miR-139-5p inhibits prolif ...... with down-regulation of c-Met
@ast
Hsa-miR-139-5p inhibits prolif ...... with down-regulation of c-Met
@en
prefLabel
Hsa-miR-139-5p inhibits prolif ...... with down-regulation of c-Met
@ast
Hsa-miR-139-5p inhibits prolif ...... with down-regulation of c-Met
@en
P2093
P2860
P356
P1433
P1476
Hsa-miR-139-5p inhibits prolif ...... with down-regulation of c-Met
@en
P2093
Chengcao Sun
Cuili Yang
Feng Zhang
Liang Wang
Xiaodong Sun
Yongyong Xi
P2860
P304
39756-39792
P356
10.18632/ONCOTARGET.5476
P407
P577
2015-10-14T00:00:00Z